152 related articles for article (PubMed ID: 17570682)
21. CSF alpha-synuclein levels in dementia with Lewy bodies and Alzheimer's disease.
Noguchi-Shinohara M; Tokuda T; Yoshita M; Kasai T; Ono K; Nakagawa M; El-Agnaf OM; Yamada M
Brain Res; 2009 Jan; 1251():1-6. PubMed ID: 19071095
[TBL] [Abstract][Full Text] [Related]
22. MR features of the substantia innominata and therapeutic implications in dementias.
Hanyu H; Shimizu S; Tanaka Y; Hirao K; Iwamoto T; Abe K
Neurobiol Aging; 2007 Apr; 28(4):548-54. PubMed ID: 16569466
[TBL] [Abstract][Full Text] [Related]
23. Patients with dementia with lewy bodies have more impaired quality of life than patients with Alzheimer disease.
Boström F; Jönsson L; Minthon L; Londos E
Alzheimer Dis Assoc Disord; 2007; 21(2):150-4. PubMed ID: 17545741
[TBL] [Abstract][Full Text] [Related]
24. Phenylephrine and pilocarpine eye drop test for dementia with Lewy bodies and Alzheimer's disease.
Hanyu H; Hirao K; Shimizu S; Kanetaka H; Sakurai H; Iwamoto T
Neurosci Lett; 2007 Mar; 414(2):174-7. PubMed ID: 17197083
[TBL] [Abstract][Full Text] [Related]
25. EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up.
Bonanni L; Thomas A; Tiraboschi P; Perfetti B; Varanese S; Onofrj M
Brain; 2008 Mar; 131(Pt 3):690-705. PubMed ID: 18202105
[TBL] [Abstract][Full Text] [Related]
26. Dementia.
Nardone R; Golaszewski S; Trinka E
Handb Clin Neurol; 2013; 116():599-611. PubMed ID: 24112927
[TBL] [Abstract][Full Text] [Related]
27. Dysfunctions of cortical excitability in drug-naïve posttraumatic stress disorder patients.
Rossi S; De Capua A; Tavanti M; Calossi S; Polizzotto NR; Mantovani A; Falzarano V; Bossini L; Passero S; Bartalini S; Ulivelli M
Biol Psychiatry; 2009 Jul; 66(1):54-61. PubMed ID: 19368897
[TBL] [Abstract][Full Text] [Related]
28. Sensory afferent inhibition within and between limbs in humans.
Bikmullina R; Bäumer T; Zittel S; Münchau A
Clin Neurophysiol; 2009 Mar; 120(3):610-8. PubMed ID: 19136299
[TBL] [Abstract][Full Text] [Related]
29. Normal cortical excitability in Myoclonus-Dystonia--a TMS study.
van der Salm SM; van Rootselaar AF; Foncke EM; Koelman JH; Bour LJ; Bhatia KP; Rothwell JC; Tijssen MA
Exp Neurol; 2009 Apr; 216(2):300-5. PubMed ID: 19118553
[TBL] [Abstract][Full Text] [Related]
30. Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation.
Di Lazzaro V; Oliviero A; Tonali PA; Marra C; Daniele A; Profice P; Saturno E; Pilato F; Masullo C; Rothwell JC
Neurology; 2002 Aug; 59(3):392-7. PubMed ID: 12177373
[TBL] [Abstract][Full Text] [Related]
31. Changes in intracortical circuits of the human motor cortex following theta burst stimulation of the lateral cerebellum.
Koch G; Mori F; Marconi B; Codecà C; Pecchioli C; Salerno S; Torriero S; Lo Gerfo E; Mir P; Oliveri M; Caltagirone C
Clin Neurophysiol; 2008 Nov; 119(11):2559-69. PubMed ID: 18824403
[TBL] [Abstract][Full Text] [Related]
32. Reduced cerebral cortex inhibition in dystonia: direct evidence in humans.
Di Lazzaro V; Oliviero A; Profice P; Dileone M; Pilato F; Insola A; Della Marca G; Tonali PA; Mazzone P
Clin Neurophysiol; 2009 Apr; 120(4):834-9. PubMed ID: 19268631
[TBL] [Abstract][Full Text] [Related]
33. Dopamine modulates cholinergic cortical excitability in Alzheimer's disease patients.
Martorana A; Mori F; Esposito Z; Kusayanagi H; Monteleone F; Codecà C; Sancesario G; Bernardi G; Koch G
Neuropsychopharmacology; 2009 Sep; 34(10):2323-8. PubMed ID: 19516251
[TBL] [Abstract][Full Text] [Related]
34. Cortical disinhibition in diabetic patients with neuropathic pain.
Turgut N; Altun BU
Acta Neurol Scand; 2009 Dec; 120(6):383-8. PubMed ID: 19922582
[TBL] [Abstract][Full Text] [Related]
35. Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy.
Schmeichel AM; Buchhalter LC; Low PA; Parisi JE; Boeve BW; Sandroni P; Benarroch EE
Neurology; 2008 Jan; 70(5):368-73. PubMed ID: 18227417
[TBL] [Abstract][Full Text] [Related]
36. Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.
Parnetti L; Tiraboschi P; Lanari A; Peducci M; Padiglioni C; D'Amore C; Pierguidi L; Tambasco N; Rossi A; Calabresi P
Biol Psychiatry; 2008 Nov; 64(10):850-5. PubMed ID: 18395699
[TBL] [Abstract][Full Text] [Related]
37. Reappraisal of a consecutive autopsy series of patients with primary degenerative dementia: Lewy-related pathology.
Oinas M; Sulkava R; Polvikoski T; Kalimo H; Paetau A
APMIS; 2007 Jul; 115(7):820-7. PubMed ID: 17614849
[TBL] [Abstract][Full Text] [Related]
38. Default network is not hypoactive in dementia with fluctuating cognition: an Alzheimer disease/dementia with Lewy bodies comparison.
Franciotti R; Falasca NW; Bonanni L; Anzellotti F; Maruotti V; Comani S; Thomas A; Tartaro A; Taylor JP; Onofrj M
Neurobiol Aging; 2013 Apr; 34(4):1148-58. PubMed ID: 23063646
[TBL] [Abstract][Full Text] [Related]
39. Depression associated with dementia with Lewy bodies (DLB) and the effect of somatotherapy.
Takahashi S; Mizukami K; Yasuno F; Asada T
Psychogeriatrics; 2009 Jun; 9(2):56-61. PubMed ID: 19604326
[TBL] [Abstract][Full Text] [Related]
40. Reduced CSF CART in dementia with Lewy bodies.
Schultz K; Wiehager S; Nilsson K; Nielsen JE; Lindquist SG; Hjermind LE; Andersen BB; Wallin A; Nilsson C; Petersén A
Neurosci Lett; 2009 Apr; 453(2):104-6. PubMed ID: 19356602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
